Session Chairs

Anne Borgman, MD
Vice President & Head of Hematology-Oncology Clinical Development
Jazz Pharmaceuticals

Davy Chiodin, PharmD
Senior Vice President of Product Development
Day One Biopharmaceuticals

Don Corson, PhD
DTC Consulting

Mark Kieran, MD, PhD
Senior Director, Global Drug Development, Pediatric Oncology 
Bristol-Myers Squibb

Jeffrey Skolnik, MD
Vice President, Clinical Development
Inovio Pharmaceuticals, Inc

Louis Stancato, PhD
Research Fellow, Pediatric Capabilities
Eli Lilly and Company

Session Speakers

Greg Reaman
U.S. Food and Drug Administration

Geoffrey S. Kannan, PhD, MD
Medical Director, Oncology, Covance